Abstract

Background Scrophularia dentata is an important medicinal plant and used for the treatment of exanthema and fever in Traditional Tibetan Medicine. Scrodentoids H and I (SHI), a pair of epimerides of C19-norditerpenoids isolated from Scrophularia dentata, could transfer to each other in room temperature and were firstly reported in our previous work. Here, we first reported the anti-inflammatory effects of SHI on LPS-induced inflammation. Purpose To evaluate the anti-inflammatory property of SHI, we investigated the effects of SHI on LPS-activated THP-1 cells. Methods THP-1 human macrophages were pretreated with SHI and stimulated with LPS. Proinflammatory cytokines IL-1β and IL-6 were measured by RT-PCR and enzyme-linked immunosorbent assays (ELISA). The mechanism of action involving phosphorylation of ERK, JNK, P38, and STAT3 was measured by western Blot. The NF-κB promoter activity was evaluated by Dual-Luciferase Reporter Assay System in TNF-α stimulated 293T cells. Results SHI dose-dependently reduced the production of proinflammatory cytokines IL-1β and IL-6. The ability of SHI to reduce production of cytokines is associated with phosphorylation depress of JNK and STAT3 rather than p38, ERK, and NF-κB promoter. Conclusions Our experimental results indicated that anti-inflammatory effects of SHI exhibit attenuation of LPS-induced inflammation and inhibit activation through JNK/STAT3 pathway in macrophages. These results suggest that SHI might have a potential in treating inflammatory disease.

Highlights

  • Inflammation is a series of complex physiological reactions caused by persistent infection or dysregulation of immune responses in healthy tissues

  • We found that the mRNA levels of IL-1β (Figure 2(a)) and IL-6 (Figure 2(b)) were significantly increased after LPS-stimulated THP-1 cells for 4 h, and Scrodentoids H and I (SHI) significantly inhibited the expression of IL-1β and IL-6

  • To further confirm the relationship between the anti-inflammation effect of SHI and Jun N-terminal kinase (JNK) signaling pathway, we investigated the effect of JNK- inhibition on IL-1β and IL-6 mRNA levels. us, THP-1 cells were pretreated with SHI for 1 h, followed by LPS stimulated for 4 h

Read more

Summary

Background

We first reported the anti-inflammatory effects of SHI on LPS-induced inflammation. To evaluate the anti-inflammatory property of SHI, we investigated the effects of SHI on LPS-activated THP-1 cells. THP-1 human macrophages were pretreated with SHI and stimulated with LPS. E mechanism of action involving phosphorylation of ERK, JNK, P38, and STAT3 was measured by western Blot. E NF-κB promoter activity was evaluated by Dual-Luciferase Reporter Assay System in TNF-α stimulated 293T cells. SHI dose-dependently reduced the production of proinflammatory cytokines IL-1β and IL-6. E ability of SHI to reduce production of cytokines is associated with phosphorylation depress of JNK and STAT3 rather than p38, ERK, and NF-κB promoter. Our experimental results indicated that anti-inflammatory effects of SHI exhibit attenuation of LPS-induced inflammation and inhibit activation through JNK/STAT3 pathway in macrophages. Our experimental results indicated that anti-inflammatory effects of SHI exhibit attenuation of LPS-induced inflammation and inhibit activation through JNK/STAT3 pathway in macrophages. ese results suggest that SHI might have a potential in treating inflammatory disease

Introduction
Materials and Methods
Result
Findings
Discussion
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.